Clariane SE
Short position disclosed on November 11, 2025.
Evolution of the disclosed total
July 20, 2017 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Hrteu Limited | 0.99% | unchanged | November 22, 2024 | AMF | |
| Jpmorgan Asset Management (UK) Limited | 0.50% | new | November 11, 2025 | AMF |
In the United States KRNMF (OTC): 40,689 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Clariane SE Titelia
Get the moves on Clariane SE by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| August 2, 2017 | Blackrock Investment Management (UK) Limited | 0.59% | March 7, 2018 | |
| July 25, 2017 | Blackrock Investment Management (UK) Limited | 0.61% | March 7, 2018 | |
| July 20, 2017 | Blackrock Investment Management (UK) Limited | 0.52% | March 7, 2018 |
The AMF column opens the filing the fund itself lodged, on the regulator own site.
Download 253 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.35% of the capital sold short
- Valeo 11.29% of the capital sold short
- Renault 9.50% of the capital sold short
- Viridien 8.39% of the capital sold short
- Teleperformance 6.31% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Alstom 4.57% of the capital sold short
- Elis 4.57% of the capital sold short
- Abivax 4.47% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- DBV Technologies 4.21% of the capital sold short
- VusionGroup 3.91% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Clariane SE, source AMF, data as at November 11, 2025, https://www.quivad.com/action/clariane-se?page=6